TrianglePUBLICATIONS · 20194854
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2010 Apr 1
- First author
- Colucci G
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Colucci G
- type
- Author
- name
- Labianca R
- type
- Author
- name
- Di Costanzo F
- type
- Author
- name
- Gebbia V
- type
- Author
- name
- Cartenì G
- type
- Author
- name
- Massidda B
- type
- Author
- name
- Dapretto E
- type
- Author
- name
- Manzione L
- type
- Author
- name
- Piazza E
- type
- Author
- name
- Sannicolò M
- type
- Author
- name
- Ciaparrone M
- type
- Author
- name
- Cavanna L
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Colucci G
- type
- Author
- name
- Labianca R
- type
- Author
- name
- Di Costanzo F
- type
- Author
- name
- Gebbia V
- type
- Author
- name
- Cartenì G
- type
- Author
- name
- Massidda B
- type
- Author
- name
- Dapretto E
- type
- Author
- name
- Manzione L
- type
- Author
- name
- Piazza E
- type
- Author
- name
- Sannicolò M
- type
- Author
- name
- Ciaparrone M
- type
- Author
- name
- Cavanna L
- type
- Author
- bibliography ids
- nci-bib-fd42daafdbe43fee7ad25015
- book metadata
- content sha256
- cc33a919443b36af0d44f14d01e50faa8fae834307b54b5d627acf716cb3d5b4
- document type
- citation
- dois
- 10.1200/JCO.2009.25.4433
- electronic publication date
- display
- 2010 Mar 1
- precision
- day
- year
- 2010
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:20194854
- immutable id
- pubmed:20194854@cc33a919443b36af0d44f14d01e50faa8fae834307b54b5d627acf716cb3d5b4
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 10
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1645-51
- volume
- 28
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 20194854
- provenance
- batch id
- 708c7929ee1eff455330
- provider
- NCBI PubMed ESummary
- record sha256
- d2081334c2a388d93d35e441801a1e6427a86313711c080c1b617b18567d1ca6
- response sha256
- d245af3dbc636ffc79325b3798c7bfda16faf0a3d796681b12b8d89bd68eb450
- retrieved at
- 2026-09-09T23:46:31.496840+00:00
- publication date
- display
- 2010 Apr 1
- precision
- day
- year
- 2010
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.
Preserved source evidence · Not medical advice